Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |